WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹643 Cr | ₹882 Cr | ₹866 Cr | ₹840 Cr | ₹639 Cr |
What is the latest Contingent Liabilities ratio of WOCKHARDT ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹643 Cr |
| Mar2024 | ₹882 Cr |
| Mar2023 | ₹866 Cr |
| Mar2022 | ₹840 Cr |
| Mar2021 | ₹639 Cr |
How is Contingent Liabilities of WOCKHARDT Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹643 Cr | -27.11 | |
| Mar2024 | ₹882 Cr | 1.87 | |
| Mar2023 | ₹866 Cr | 3.13 | |
| Mar2022 | ₹840 Cr | 31.46 | |
| Mar2021 | ₹639 Cr | - | |
Compare Contingent Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹32,673.9 Cr | -0.6% | 27.6% | 16.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,148.0 Cr | 2.6% | 1.2% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,009.0 Cr | 1.3% | -2.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,779.0 Cr | 1.5% | 0.7% | 37.1% | Stock Analytics | |
| CIPLA | ₹115,772.0 Cr | 6.1% | 2.4% | -5.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,616.0 Cr | 2.6% | -0.4% | -2.1% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -0.6% |
27.6% |
16.5% |
| SENSEX | -0.8% |
1.4% |
-6.8% |
You may also like the below Video Courses